AEOLUS PHARMACEUTICALS, INC.·4

Feb 20, 6:05 PM ET

Krivulka Joseph J 4

4 · AEOLUS PHARMACEUTICALS, INC. · Filed Feb 20, 2013

Insider Transaction Report

Form 4
Period: 2013-02-19
Transactions
  • Purchase

    Warrants (right to buy)

    2013-02-19+400,000400,000 total
    Exercise: $0.25From: 2013-02-19Exp: 2018-02-19Common Stock (400,000 underlying)
  • Purchase

    Common Stock, $0.01 par value per share

    2013-02-19+400,000733,333 total
Footnotes (1)
  • [F1](1) Pursuant to a Securities Purchase Agreement by and between Aeolus Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Mr. Krivulka, dated as of February 19, 2013, the Company issued and sold 400,000 Units (the "Units") to Mr. Krivulka for a purchase price of $100,000. Each Unit is comprised of one (1) share of the Company's common stock, $0.01 par value per share (the "Common Stock"), and one (1) warrant to purchase one (1) share of Common Stock with an initial exercise price of $0.25 per share of Common Stock, subject to certain adjustments.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT